REDDSTAR is an EU funded project which will develop and test stromal cell therapy to treat for diabetes mellitus. The objective is to control blood glucose while also addressing a range of diabetic complications.


Learn more about the project by visiting our patient publication section.


The REDDSTAR consortium is a network of diabetes specialists, regenerative medicine researchers, biotech industrialists and clinicians, supported by an experienced project management team.


REDDSTAR – Repair of  Diabetic Damage by Stromal Cell Administration